The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Amicus Therapeutics Inc. | Common | 03152W109 | 4,889,006 | 400,410 | SH | SOLE | 400,410 | 0 | 0 | ||
Arcutis Biotherapeutics inc | Common | 03969K108 | 3,878,621 | 262,069 | SH | SOLE | 262,069 | 0 | 0 | ||
AVROBIO, Inc. | Common | 05455M100 | 461,901 | 647,918 | SH | SOLE | 647,918 | 0 | 0 | ||
Axsome Therapeutics, Inc. | Common | 05464T104 | 4,008,832 | 51,975 | SH | SOLE | 51,975 | 0 | 0 | ||
Black Diamond Therapeutics, Inc. | Common | 09203E105 | 260,798 | 144,888 | SH | SOLE | 144,888 | 0 | 0 | ||
Chinook Therapeutics, Inc. | Common | 16961L106 | 2,096,000 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
Crinetics Pharmaceuticals Inc. | Common | 22663K107 | 6,800,994 | 371,639 | SH | SOLE | 371,639 | 0 | 0 | ||
Cullinan Oncology, Inc. | Common | 230031106 | 80,689,227 | 7,648,268 | SH | SOLE | 7,648,268 | 0 | 0 | ||
G1 Therapeutics, Inc. | Common | 3621LQ109 | 3,529,500 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
Geron Corporation | Common | 374163103 | 20,490,094 | 8,466,981 | SH | SOLE | 8,466,981 | 0 | 0 | ||
Harmony Biosciences Hldgs Inc. | Common | 413197104 | 7,679,673 | 139,377 | SH | SOLE | 139,377 | 0 | 0 | ||
Harpoon Therapeutics, Inc. | Common | 41358P106 | 2,320,809 | 3,196,707 | SH | SOLE | 3,196,707 | 0 | 0 | ||
Inhibrx, Inc Com | Common | 45720L107 | 31,697,758 | 1,286,435 | SH | SOLE | 1,286,435 | 0 | 0 | ||
Inozyme Pharma Inc. | Common | 45790W108 | 242,025 | 230,500 | SH | SOLE | 230,500 | 0 | 0 | ||
Insmed Incorporated | Common | 457669307 | 8,201,051 | 410,463 | SH | SOLE | 410,463 | 0 | 0 | ||
Intellia Therapeutics, Inc. | Common | 45826J105 | 15,883,254 | 455,238 | SH | SOLE | 455,238 | 0 | 0 | ||
Iovance Biotherapeutics Inc Com | Common | 462260100 | 13,735,625 | 2,149,550 | SH | SOLE | 2,149,550 | 0 | 0 | ||
iTeos Therapeutics, Inc. | Common | 46565G104 | 34,098,267 | 1,745,943 | SH | SOLE | 1,745,943 | 0 | 0 | ||
Iveric Bio Inc | Common | 46583P102 | 22,687,920 | 1,059,688 | SH | SOLE | 1,059,688 | 0 | 0 | ||
Madrigal Pharmaceuticals inc | Common | 558868105 | 7,770,863 | 26,773 | SH | SOLE | 26,773 | 0 | 0 | ||
Oncorus, Inc. | Common | 68236R103 | 601,389 | 2,377,031 | SH | SOLE | 2,377,031 | 0 | 0 | ||
Phathom Pharmaceuticals inc | Common | 71722W107 | 2,198,469 | 195,942 | SH | SOLE | 195,942 | 0 | 0 | ||
Praxis Precision Medicines Inc. | Common | 74006W108 | 1,451,800 | 610,000 | SH | SOLE | 610,000 | 0 | 0 | ||
Provention Bio Inc | Common | 74374N102 | 9,496,965 | 898,483 | SH | SOLE | 898,483 | 0 | 0 | ||
Reata Pharmaceuticals inc-a | Common | 75615P103 | 7,376,936 | 194,181 | SH | SOLE | 194,181 | 0 | 0 | ||
REGENXBIO Inc. | Common | 75901B107 | 14,092,717 | 621,372 | SH | SOLE | 621,372 | 0 | 0 | ||
Repare Therapeutics, Inc. | Common | 760273102 | 24,122,179 | 1,639,849 | SH | SOLE | 1,639,849 | 0 | 0 | ||
Revolution Medicines, Inc. | Common | 76155X100 | 3,550,204 | 149,043 | SH | SOLE | 149,043 | 0 | 0 | ||
TCR2 Therapeutics, Inc. | Common | 87808K106 | 3,367,611 | 3,370,982 | SH | SOLE | 3,370,982 | 0 | 0 | ||
Travere Therapeutics Inc. | Common | 89422G107 | 5,924,382 | 281,711 | SH | SOLE | 281,711 | 0 | 0 | ||
Uniqure N.V. | Common | N90064101 | 21,309,029 | 939,966 | SH | SOLE | 939,966 | 0 | 0 | ||
Verve Therapeutics, Inc | Common | 92539P101 | 15,647,590 | 808,661 | SH | SOLE | 808,661 | 0 | 0 | ||
Werewolf Therapeutics, Inc. | Common | 95075A107 | 4,895,423 | 2,388,011 | SH | SOLE | 2,388,011 | 0 | 0 |